Tien Liang BioTech Co., Ltd. (4127.TWO) — Stock Score Summary

Tien Liang BioTech Co., Ltd. (4127.TWO) has a MoatMap StockRank of 35/100 based on Quality (40/100), Value (21/100), and Momentum (62/100) factor scores. The current signal is SELL. Tien Liang BioTech is a small-cap Taiwanese health supplement distributor. It lacks scale, proprietary R&D, and any connection to our high-conviction CDMO or biotech themes.

Tien Liang BioTech Co., Ltd. develops, manufactures, and markets traditional Chinese medicines, health supplements, and over-the-counter (OTC) pharmaceutical products. The company benefits from strong brand recognition in Taiwan's consumer health market, supported by a GMP-certified manufacturing facility and an extensive pharmacy distribution network. It operates as a trusted niche player capitalizing on the growing regional demand for preventative healthcare and wellness products.

Key Financial Metrics

Price$2.03
Market Cap$101M
Price/Book6.26
Return on Equity1.3%
Return on Invested Capital-0.1%
Debt/Equity118.81
Gross Margin56.8%
Operating Margin8.9%
Revenue Growth70.0%
Free Cash Flow$-24K

Tien Liang BioTech Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Tien Liang BioTech Co., Ltd.’s (4127.TWO) StockRank?
MoatMap’s StockRank for Tien Liang BioTech Co., Ltd. (4127.TWO) is 35/100, with a Sell signal. It is a composite of Quality (40), Value (21), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tien Liang BioTech Co., Ltd. have an economic moat?
Tien Liang BioTech Co., Ltd. (4127.TWO) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tien Liang BioTech Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Tien Liang BioTech Co., Ltd. (4127.TWO) is Sell, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tien Liang BioTech Co., Ltd. in?
Tien Liang BioTech Co., Ltd. (4127.TWO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Taiwan).
Browse all ranked stocks4127.TWO deep dive reportAI ChampionsHow we score stocksSense-check another stock